Search - tctmd.com

Displaying 641 - 660 of 853

Sort: Relevancy | Date

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

Michael O'Riordan

August 14, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

Uphill Climb Seen for Implementation of US Blood Pressure Guidelines

Todd Neale

July 12, 2018

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Caitlin E. Cox

June 19, 2018

News Conference News HRS 2018

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

Todd Neale

May 18, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Conference News HRS 2018

Military Veterans With PTSD Are at Risk for A-fib

Todd Neale

May 10, 2018

News Daily News

LPA Variants Linked With CHD Events in Statin-Treated Patients

Michael O'Riordan

May 03, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Daily News

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

Michael O'Riordan

April 17, 2018

News Industry News

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

April 09, 2018

News Daily News

More CV Hospitalizations Later in Life for Mothers of Babies With Heart Defects

Caitlin E. Cox

April 02, 2018

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Shelley Wood

March 27, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Caitlin E. Cox

March 14, 2018

Advertisement

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

Uphill Climb Seen for Implementation of US Blood Pressure Guidelines

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Military Veterans With PTSD Are at Risk for A-fib

LPA Variants Linked With CHD Events in Statin-Treated Patients

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

More CV Hospitalizations Later in Life for Mothers of Babies With Heart Defects

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content